검색어: cysteamine (영어 - 몰타어)

cysteamine (mercaptamine bitartrate)
Ċisteamina (mercaptamine bitartrate)

cysteamine may cause drowsiness.
iċ-ċisteamina tista’ tikkawża n-ngħas.

immediate-release cysteamine bitartrate
bitartrat taċ-ċisteamina b’rilaxx immedjat

cystagon 150 mg hard capsules cysteamine
cystagon 150 mg kapsuli iebsin cysteamine

cysteamine excretion in human milk is unknown.
l-eskrezzjoni taċ-ċisteamina fil-ħalib tal-bniedem mhijiex magħrufa.

an overdose of cysteamine may cause progressive lethargy.
doża eċċessiva ta’ cysteamine tista’ tikkawża letarġija progressiva.

procysbi 25 mg gastro-resistant hard capsules cysteamine
procysbi 25 mg kapsuli ibsin gastro-reżistenti Ċisteamina

it is not known if cysteamine is removed by haemodialysis.
mhux magħruf jekk cysteamine jistax jitneħħa permezz ta’ dijaliżi tad-demm.

cysteamine bitartrate is not an inhibitor of oat1, oat3 and oct2.
il-bitartrat taċ-ċisteamina mhuwiex inibitur ta’ oat1, oat3 u oct2.

among cysteamine patients, glomerular function was maintained over time.
fost il-pazjenti li ngħataw cysteamine, il-funzjoni glomerulari nżammet tul il-perijodu.

post-marketing experience with immediate-release cysteamine bitartrate
esperjenza ta’ wara t-tqegħid fis-suq bil-bitartrat taċ-ċisteamina b’rilaxx immedjat

drink the mixture of cysteamine granules and acidic fruit juice.
ixrob it-taħlita ta’ frak taċ-ċisteamina u meraq tal-frott aċiduż.

the pharmacokinetics of cysteamine bitartrate has not been studied in special populations.
il-farmakokinetika tal-bitartrat taċ-ċisteamina ma ġietx studjata fil-poplazzjonijiet speċjali.

oral cysteamine has not been shown to prevent eye deposition of cystine crystals.
instab li cysteamine meħud mill-ħalq ma waqqafx id-depożitu ta’ kristalli ta' cystine fil-għajn.

each hard capsule contains 150 mg of cysteamine (as mercaptamine bitartrate) .
kull kapsula iebsa fiha 150 mg ta’ cysteamine (bħala mercaptamine bitartrate)

cysteamine has occasionally been associated with reversible leukopenia and abnormal liver function studies.
xi drabi ċ-ċisteamina ġiet assoċjata ma’ lewkopenja riversibbli u studji ta’ funzjoni anormali tal-fwied.

- in contrast to phosphocysteamine, another active substance close to cysteamine bitartrate,
- b’ kuntrast ma 'phosphocysteamine, sustanza attiva oħra viċin cysteamine bitartrate,

benign intracranial hypertension, also called pseudotumor cerebri, has been reported with cysteamine use.
ipertensjoni intrakranjali beninna, imsejħa wkoll pseudotumor cerebri, ġiet irrappurtata bl-użu taċ- ċisteamina.

therefore, where cysteamine ophthalmic solution is used for that purpose, its usage should continue.
għalhekk, fejn tintuża soluzzjoni għall-għajn għal dak l-iskop, l-użu tagħha għandu jitkompla.

cystagon is a medicine containing the active substance mercaptamine (also known as cysteamine).
cystagon huwa mediċina li fiha s-sustanza attiva merkaptamina (magħrufa wkoll bħala sisteamina).